North America Preclinical CRO Agents Market was worth USD 1.22 billion in 2018
Closed system breast pump is both the highest growing segment and revenue generating segment owing to higher benefits, such as lower risk of mold formation and contamination.
(EMAILWIRE.COM, August 20, 2018 ) A preclinical contact research organization is the guiding force for pharmaceutical companies advising how to take a drug from the research laboratories to the market. It requires various professionals including medical personnel, administrators and marketing experts.
North America Preclinical CRO Agents Market was worth USD 1.22 billion in 2018 and estimated to be growing at a CAGR of 8.14%, to reach USD 1.81 billion by 2023.
KEY POINTS OF TOC:
5. Market Segmentation
5.1 Service type
5.1.1 Introduction
5.1.2 Bioanalysis and DMPK studies
5.1.3 Toxicology testing
5.1.4 Other preclinical services
5.1.5 Y-o-Y Growth Analysis, By service type
5.1.6 Market Attractiveness Analysis, By service type
5.1.7 Market Share Analysis, By service type
Request sample report @ https://www.marketdataforecast.com/market-reports/north-america-preclinical-cro-agents-market-6691/request-sample
5.2 End user
5.2.1 Introduction
5.2.2 Biopharmaceutical companies
5.2.3 Government and academic institutes
5.2.4 Medical device companies
5.2.5 Y-o-Y Growth Analysis, By end user
5.2.6 Market Attractiveness Analysis, By end user
5.2.7 Market Share Analysis, By end user
Browse full report @ https://www.marketdataforecast.com/market-reports/north-america-preclinical-cro-agents-market-6691/
On the basis of geography, the market is analysed under various regions namely U.S.A and Canda. The Preclinical CRO Agents market was dominated by North America.
Some of the major companies dominating the market, by their products and services include Charles River Laboratories International, Inc.; Laboratory Corporation of America; Envigo, Eurofins Scientific; PRA Health Science, Inc.; Wuxi AppTec; Medpace, Inc.; Pharmaceutical Product Development, LLC.; and Paraxel International Corporation.
Request discount @ https://www.marketdataforecast.com/market-reports/north-america-preclinical-cro-agents-market-6691/request-discount
North America Preclinical CRO Agents Market was worth USD 1.22 billion in 2018 and estimated to be growing at a CAGR of 8.14%, to reach USD 1.81 billion by 2023.
KEY POINTS OF TOC:
5. Market Segmentation
5.1 Service type
5.1.1 Introduction
5.1.2 Bioanalysis and DMPK studies
5.1.3 Toxicology testing
5.1.4 Other preclinical services
5.1.5 Y-o-Y Growth Analysis, By service type
5.1.6 Market Attractiveness Analysis, By service type
5.1.7 Market Share Analysis, By service type
Request sample report @ https://www.marketdataforecast.com/market-reports/north-america-preclinical-cro-agents-market-6691/request-sample
5.2 End user
5.2.1 Introduction
5.2.2 Biopharmaceutical companies
5.2.3 Government and academic institutes
5.2.4 Medical device companies
5.2.5 Y-o-Y Growth Analysis, By end user
5.2.6 Market Attractiveness Analysis, By end user
5.2.7 Market Share Analysis, By end user
Browse full report @ https://www.marketdataforecast.com/market-reports/north-america-preclinical-cro-agents-market-6691/
On the basis of geography, the market is analysed under various regions namely U.S.A and Canda. The Preclinical CRO Agents market was dominated by North America.
Some of the major companies dominating the market, by their products and services include Charles River Laboratories International, Inc.; Laboratory Corporation of America; Envigo, Eurofins Scientific; PRA Health Science, Inc.; Wuxi AppTec; Medpace, Inc.; Pharmaceutical Product Development, LLC.; and Paraxel International Corporation.
Request discount @ https://www.marketdataforecast.com/market-reports/north-america-preclinical-cro-agents-market-6691/request-discount
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results